00648 SOFTMEDX
- 0.380
- 0.0000.00%
SOFTMEDX News
SoftMedx Healthcare Returns to Profit in 2023
SoftMedx Healthcare (HKG:0648) recorded an attributable profit of HK$12.5 million for the year 2023, as compared to an attributable loss of HK$19.2 million in 2022, according to a Wednesday annual rep
京玖康療-新：二零二三年年報
Jingjiu Health (00648) announced annual results. Shareholders' profit attributable to shareholders was HK$1,2511 million, turning a year-on-year loss into a profit
Jingjiu Health (00648) announced its 2023 annual results, with revenue of HK$51.34 million, an increase of 52.05 over the previous year...
SOFTMEDX: 2023 FINAL RESULTS
Jingjiu Health (00648.HK) will hold a board meeting on March 27 to approve the annual results
Gelonghui March 12 | Jingjiu Health (00648.HK) issued an announcement. The board of directors will hold a board meeting on March 27, 2024 to approve the publication of the annual results of the company and its subsidiaries as of December 31, 2023.
SOFTMEDX: DATE OF BOARD MEETING
Jingjiu Health: The Stock Exchange informs the company that it will not exercise its right to delist the company for the time being
Jingjiu Health (00648) issued an announcement. On April 21, 2024, the Stock Exchange informed that it will not exercise its right to delist the company in accordance with section 6.01A (2) (b) (i) of the listing rules, subject to further developments in the company's petition to the Securities Regulatory Commission, and may exercise its rights in accordance with section 6.01A of the Listing Rules at a later stage if it deems appropriate. The company will continue to gradually address the concerns of the Securities Regulatory Commission and the Stock Exchange. The company is mainly engaged in the distribution of medical equipment and products in Hong Kong, which involves the medical business of dental equipment and products. The Group's business operations focus on everything
Jingjiu Health (00648): The Stock Exchange informs the company that it will not exercise its right to delist the company
Jingjiu Health (00648) issued an announcement. On April 21, 2024, the Stock Exchange informed the company that it will not follow...
Jingjiu Health: Business operations are carried out as usual in all major aspects
Jingjiu Health (00648) issued an announcement. On April 21, 2020, the Stock Exchange informed that it will not exercise its right to delist the company in accordance with section 6.01A (2) (b) of the listing rules, subject to further developments in the company's petition to the Securities Regulatory Commission, and may exercise its rights in accordance with section 6.01A of the listing rules at a later stage if it deems appropriate. The company will continue to gradually address the concerns of the Securities Regulatory Commission and the Stock Exchange. The company is mainly engaged in medical business, and all major aspects of its business operations are carried out as usual. The Board will continue to evaluate and monitor the suspension of trading on the Group's operations and finances
Jingjiu Health (00648): Business operations are carried out as usual in all major aspects
Jingjiu Health (00648) issued an announcement. On April 21, 2020, the Stock Exchange informed the company that it will not follow...
Hong Kong High Court Dismisses Winding-Up Petition Against SoftMedx Healthcare
The High Court of Hong Kong dismissed the winding-up petition against SoftMedx Healthcare (HKG:0648) on Monday, Jan. 22. The petition was related to an alleged unpaid debt of HK$16.2 million. Trading
Jingjiu Health (00648): Liquidation petition withdrawn
Jingjiu Health (00648) issued an announcement. The Hong Kong High Court issued an order to cancel the winding-up on January 22, 2024...
Jingjiu Health (00648): Trading will continue to be suspended until the conditions for resumption of trading are met
Jingjiu Health (00648) issued an announcement. The Hong Kong court's order approving the plan has been registered and issued in the Hong Kong Companies Registry...
Winding-Up Petition Hearing Against SoftMedx Healthcare Further Adjourned by Hong Kong Court
The High Court of Hong Kong has further adjourned a winding-up petition hearing against SoftMedx Healthcare (HKG:0648) to Jan. 22, 2024, a Monday filing stated. The company had been slapped with the p
Jingjiu Health (00648.HK): Postponing the hearing of the winding-up petition
Glonghui, December 4, Jingjiu Health (00648.HK) announced that on December 4, 2023, the Hong Kong High Court issued an order to postpone the hearing of the winding-up petition until January 22, 2024.
Winding-Up Hearing Against SoftMedx Healthcare Further Adjourned
The Hong Kong High Court has adjourned the hearing of a winding up petition against SoftMedx Healthcare (HKG:0648) to Dec. 4, according to a Thursday filing. The healthcare company had been slapped wi
Jingjiu Health (00648): Court orders adjourning the hearing of the winding-up petition until December 4
Jingjiu Health (00648) issued a notice. On November 29, 2023, the High Court of Hong Kong issued an order to liquidate...
Winding-Up Petition Hearing Against SoftMedx Healthcare Adjourned
The High Court of Hong Kong adjourned the winding up petition hearing against SoftMedx Healthcare (HKG:0648) to Nov. 29, according to a Wednesday disclosure. A creditor filed the petition against the
Jingjiu Health (00648): Hearing of winding-up petition postponed to November 29
Jingjiu Health (00648) issued a notice. On November 8, 2023, the High Court of Hong Kong issued an order to liquidate the petition...
Jingjiu Healthcare (00648.HK) will continue to suspend trading until the conditions for resumption of trading are met
Gelonghui November 6丨Jingjiu Health (00648.HK) announced that trading of the company's shares will continue to be suspended until the conditions for resumption of trading are reached.
Analysis
Price Target
No Data
